On July 29, 2015, more than 50 organizations, representing 500,000 patients, doctors, and researchers in the United States, came together to launch the AllTrials campaign in the U.S.
They join a worldwide campaign calling for every clinical trial—past, present, and future—to be registered and the results from it reported.
Why? Because we want to fix medicine and science.
The results of roughly more than half of all clinical trials remain hidden; trials with positive results are twice as likely to be published as trials with negative results.
How did the quest for these withheld trial results begin? Watch the story of AllTrials—the little campaign that’s changing the world.
More than 682 organizations have endorsed the AllTrials campaign, including medical associations, patient groups, scientific societies, and even pharmaceutical companies.
And over 88,000 people have signed the AllTrials petition.
Among those supporters are researchers like Jennifer Miller, Ph.D., a bioethicist at New York University. Miller came up with a way to evaluate the transparency of pharmaceutical companies with her Good Pharma Scorecard. Watch the profile to learn more.
The AllTrials campaign started with a single donation of $8,000 in 2013. Since then, over 3,000 people have donated to the campaign, helping to turn it into a global phenomenon.
Every little bit helps; you can donate here.
AllTrials is an initiative of Ben Goldacre, BMJ, Centre for Evidence-based Medicine, Cochrane Collaboration, James Lind Initiative, PLOS and Sense About Science, and is being led in the U.S. by Sense About Science USA, Dartmouth’s Geisel School of Medicine and the Dartmouth Institute for Health Policy & Clinical Practice.